Newton Charles W. bought LYEL
August 20, 2025 · Form 4 insider transaction
Newton Charles W. bought 8,000 shares of Lyell Immunopharma, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
8,000
Price
$0.00
Total value
N/A
InsiderNewton Charles W.
RoleOfficer, Director
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateAugust 20, 2025
Filing dateAugust 22, 2025
Shares owned after16,759
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Pursuant to performance-based restricted stock units granted to the reporting person on February 9, 2024, 4,000 shares were issued on the Transaction Date upon the achievement of certain performance criteria certified by the compensation committee of the Issuer's board of directors on the Transaction Date and 4,000 shares will be issued on August 20, 2026, subject to the reporting person providing service through such date.